Drug name - Fotivda

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6821987 AVEO PHARMS Quinoline derivatives and quinazoline derivatives having azolyl group
Apr, 2023

(6 months from now)

US7166722 AVEO PHARMS N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n′-(5-methyl-3-isoxazolyl)urea salt in crystalline form
Nov, 2023

(1 year, 1 month from now)

CN1543459A AVEO PHARMS A Group Of Quinoline Derivatives And Quinazoline Derivatives
Apr, 2022

(5 months ago)

CN1273466C AVEO PHARMS A Group Of Quinoline Derivatives And Quinazoline Derivatives
Apr, 2022

(5 months ago)

IN200301649P1 AVEO PHARMS Quinoline And Quinazoline Compounds
Apr, 2022

(5 months ago)

IN217759B AVEO PHARMS Quinoline And Quinazoline Compounds
Apr, 2022

(5 months ago)

EP1652847A3 AVEO PHARMS Quinoline And Quinazoline Derivatives For The Treatment Of Tumors
Apr, 2022

(5 months ago)

EP1652847B1 AVEO PHARMS Quinoline And Quinazoline Derivatives For The Treatment Of Tumors
Apr, 2022

(5 months ago)

EP1652847A1 AVEO PHARMS Quinoline And Quinazoline Derivatives For The Treatment Of Tumors
Apr, 2022

(5 months ago)

EP1382604B1 AVEO PHARMS Quinoline Derivative Having Azolyl Group And Quinazoline Derivative
Apr, 2022

(5 months ago)

EP1382604A4 AVEO PHARMS Quinoline Derivative Having Azolyl Group And Quinazoline Derivative
Apr, 2022

(5 months ago)

EP1382604A1 AVEO PHARMS Quinoline Derivative Having Azolyl Group And Quinazoline Derivative
Apr, 2022

(5 months ago)

EP1559715A1 AVEO PHARMS N-{2-Chloro-4-[(6,7-Dimethoxy-4-Quinolyl)Oxy]Phenyl}-N'-(5-Methyl-3-Isoxazolyl)Urea Salt In Crystalline Form
Oct, 2023

(1 year, 16 days from now)

EP1559715A4 AVEO PHARMS N-¬2-Chloro-4-(6,7-Dimethoxy-4-Quinolyl)OxyPhenyl-N'-(5-Methyl-3-Isoxazolyl)Urea Salt In Crystalline Form
Oct, 2023

(1 year, 16 days from now)

EP1559715B1 AVEO PHARMS N-{2-Chloro-4-[(6,7-Dimethoxy-4-Quinolyl)Oxy]Phenyl}-N'-(5-Methyl-3-Isoxazolyl)Urea Salt In Crystalline Form
Oct, 2023

(1 year, 16 days from now)

More Information on Dosage
Strength Dosage Availability
EQ 0.89MG BASE CAPSULE;ORAL Prescription
EQ 1.34MG BASE CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.